CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE

.

Saved in:

Bibliographic Details
Main Authors:	E.N. Fedulova, O.A. Tutina, O.V. Fedorova, L.V. Beier, S.A. Abramov, A.R. Bogomolov
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2009-08-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/1000
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MEDICAL NUTRITION FOR NON SPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE IN CHILDREN
by: O.A. Tutina, et al.
Published: (2008-09-01)

DIFFICULTY IN DIAGNOSTICS TO VERIFY CROHN’S DISEASE IN CHILDREN. CLINICAL CASE STUDY
by: E.N. Fedulova, et al.
Published: (2010-03-01)

SORPTION РATHOGENETIC THERAPY OF ENDOGENOUS INTOXICATION OF PEDIATRIC CHRONIC INFLAMMATORY BOWEL DISEASES
by: O.V. Fedorova, et al.
Published: (2009-10-01)

MORPHOLOGICAL CRITERIA FOR PREDICTION OF SEVERITY OF CROHN’S DISEASE CLINICAL COURSE IN CHILDREN
by: E. N. Fedulova, et al.
Published: (2013-09-01)

VARIANTS OF NONSPECIFIC ULCERATIVE COLITIS COURSE IN CHILDREN: PREDICTION AND TREATMENT
by: E.N. Fedulova, et al.
Published: (2009-06-01)

FUNCTIONAL FECAL INCONTINENCE IN CHILDREN (DIFFERENTIAL DIAGNOSTICS AND TREATMENT APPROACHES)
by: V.N. Kopeikin, et al.
Published: (2009-10-01)

USE OF COMBINED THERAPY WITH LOCALIZED ADMINISTRATION OF INFLIXIMAB IN CHILDREN WITH CONTINUOUSLY RECURRENT PERIANAL CROHN’S DISEASE
by: O.V. Shcherbakova
Published: (2010-07-01)

Infliximab in the Treatment of Crohn’s Disease
by: Brian Feagan
Published: (2000-01-01)

Listeria Meningitis Complicating Infliximab Treatment for Crohn’s Disease
by: Geoffrey Williams, et al.
Published: (2005-01-01)

Crohn's disease of the vulva in a 10-year-old girl
by: Zarife Kuloğlu, et al.
Published: (2008-04-01)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
by: Dario Sorrentino, et al.
Published: (2015-01-01)

Demyelination-Like Syndrome In Crohn’s Disease After Infliximab Therapy
by: Hugh J Freeman, et al.
Published: (2005-01-01)

Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease
by: Yoon Zi Kim, et al.
Published: (2025-07-01)

Long-Term Response Rates to Infliximab Therapy for Crohn’s Disease in an Outpatient Cohort
by: Christopher W Teshima, et al.
Published: (2009-01-01)

Improvement with Infliximab of a Disseminated Sarcoidosis in a Patient with Crohn’s Disease
by: Nader Chebib, et al.
Published: (2014-01-01)

Infliximab for the Treatment of Crohn'S Disease: Review and Indications for Clinical Use in Canada
by: Remo Panaccione
Published: (2001-01-01)

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

A Rare Benign Tumor in a 14-Year-Old Girl
by: Meral Hassan Abualjadayel, et al.
Published: (2018-01-01)

Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease
by: Liji Chen, et al.
Published: (2025-08-01)

A literature survey on follow-up definitions on the use of infliximab in Crohn’s disease
by: Andy Wai Kan Yeung
Published: (2025-08-01)

Clinical Experience with Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta
by: Clifford Sample, et al.
Published: (2002-01-01)

Atypical Manifestation of Crohn’s Disease in a Teenage Girl
by: E. V. Donskaya, et al.
Published: (2021-04-01)

Hereditary Papulotranslucent Acrokeratoderma in a 14-year-old Girl
by: Rashmi Jindal, et al.
Published: (2025-07-01)

Cystosarcoma phyllodes. A malignant cystosarcoma phyllodes in a 14-year-old girl
by: D Oğün, et al.
Published: (1986-07-01)

Topical steroids as alternative to systemic hormonal treatment for inflammatory bowel diseases in pediatric practice
by: E. N. Fedulova, et al.
Published: (2011-05-01)

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis
by: Andy Wai Kan Yeung
Published: (2024-11-01)

Hepatitis B Virus Reactivation Induced by Infliximab Administration in a Patient with Crohn’s Disease
by: Yuka Miyake, et al.
Published: (2013-01-01)

Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn’s disease
by: Pauline Wils, et al.
Published: (2025-03-01)

Application of morphological criteria for definition of management approach for child with ulcerative colitis
by: E. N. Fedulova, et al.
Published: (2012-07-01)

Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn’s disease: a randomised, controlled, open-label trial
by: Yang Yang, et al.
Published: (2020-11-01)

Fulminant Legionellosis in Two Patients Treated with Infliximab for Crohn’s Disease: Case Series and Literature Review
by: Adam Hofmann, et al.
Published: (2009-01-01)

Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients
by: Jiao Zheng, et al.
Published: (2025-06-01)

The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study
by: Chen Huang, et al.
Published: (2025-06-01)

Infliximab monitoring in Crohn’s disease: a neural network approach for evaluating disease activity and immunogenicity
by: Luis Eduardo Miani Gomes, et al.
Published: (2024-05-01)

INFLIXIMAB IN TREATMENT OF ACTIVE JUVENILE ARTHRITIS
by: E. S. Zholobova, et al.
Published: (2012-05-01)

A Clinical Case: Incoming Diagnosis of Crohn’s Disease at a Gastroenterologist’s Appointment
by: Volgina, I.M., et al.
Published: (2025-06-01)

Anaplastic Large Cell Lymphoma of the Colon in a Patient with Colonic Crohn Disease Treated with Infliximab and Methotrexate
by: Tushar Shukla, et al.
Published: (2014-01-01)

Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment
by: Lixuan Li, et al.
Published: (2025-07-01)

The Impact of Intermediate Antidrug Antibodies to Infliximab and Adalimumab on Clinical Outcomes in Patients with Crohn’s Disease or Ulcerative Colitis
by: Chaoyang Wang, et al.
Published: (2022-03-01)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
by: Magdalena Kaniewska, et al.
Published: (2020-11-01)